『Research To Practice | Oncology Videos』のカバーアート

Research To Practice | Oncology Videos

Research To Practice | Oncology Videos

著者： Dr Neil Love
無料で聴く

このコンテンツについて

 Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.Copyright © 2023 Research To Practice. All Rights Reserved. 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Endometrial and Cervical Cancer | Susana Banerjee, MBBS, MA, PhD

    Endometrial and Cervical Cancer | Susana Banerjee, MBBS, MA, PhD
    2025/08/01

    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Gynecologic Cancers | Faculty Presentation 2: Endometrial Cancer and Cervical Cancer — Susana Banerjee, MBBS, MA, PhD

    CME information and select publications
    続きを読む 一部表示
    28 分
  • Ovarian Cancer | Ursula Matulonis, MD

    Ovarian Cancer | Ursula Matulonis, MD
    2025/07/31

    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Gynecologic Cancers | Faculty Presentation 1: Ovarian Cancer — Ursula Matulonis, MD

    CME information and select publications
    続きを読む 一部表示
    36 分
  • Oncology Nursing Update: Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient Care

    Oncology Nursing Update: Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient Care
    2025/07/30

    Featuring an interview with Ms Kathleen D Burns, including the following topics:

    • Case: A man in his early 70s with metastatic hormone-sensitive prostate cancer who received an androgen receptor inhibitor in combination with androgen deprivation therapy (0:00)
    • Case: A man in his early 70s with metastatic castration-resistant prostate cancer (mCRPC) who received olaparib in combination with abiraterone (23:20)
    • Case: A man in his mid 70s with mCRPC who received lutetium Lu 177 vipivotide tetraxetan (33:44)

    NCPD information and select publications
    続きを読む 一部表示
    44 分
まだレビューはありません